Global Glabridin (CAS 59870-68-7) Competitive Landscape Professional Research Report 2025

Research Summary

Glabridin (CAS 59870-68-7) is a natural compound extracted from the root of licorice (Glycyrrhiza glabra) and is known for its various biological activities. This plant-derived substance is commonly used in cosmetics and skincare products due to its skin-brightening and anti-inflammatory properties. Glabridin inhibits tyrosinase, an enzyme involved in the production of melanin, making it a sought-after ingredient in formulations aiming to lighten hyperpigmentation and even out skin tone. Additionally, glabridin exhibits antioxidant effects, providing potential benefits for protecting the skin against oxidative stress. The compound has garnered attention in the cosmetic and pharmaceutical industries for its potential role in promoting skin health and addressing various dermatological concerns.

According to DIResearch's in-depth investigation and research, the global Glabridin (CAS 59870-68-7) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Glabridin (CAS 59870-68-7) include Sabinsa, Alchem International, MAFCO, Plamed Green Science Group, Xi＇an Zhongying, Spring Autumn Biological, Huaian Brothers Biotechnology, Xi’an Tianye Biotech, SK Bioland, Maruzen Pharmaceuticals, Sunpure Extracts etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Glabridin (CAS 59870-68-7). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Glabridin (CAS 59870-68-7) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Glabridin (CAS 59870-68-7) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Glabridin (CAS 59870-68-7) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Glabridin (CAS 59870-68-7) Include:

Sabinsa

Alchem International

MAFCO

Plamed Green Science Group

Xi＇an Zhongying

Spring Autumn Biological

Huaian Brothers Biotechnology

Xi’an Tianye Biotech

SK Bioland

Maruzen Pharmaceuticals

Sunpure Extracts

Glabridin (CAS 59870-68-7) Product Segment Include:

20% (HPLC)

40% (HPLC)

60% (HPLC)

90% (HPLC)

98% (HPLC)

Other

Glabridin (CAS 59870-68-7) Product Application Include:

Cosmetic

Pharmaceutical

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Glabridin (CAS 59870-68-7) Capacity and Production Analysis

Chapter 3: Global Glabridin (CAS 59870-68-7) Industry PESTEL Analysis

Chapter 4: Global Glabridin (CAS 59870-68-7) Industry Porter's Five Forces Analysis

Chapter 5: Global Glabridin (CAS 59870-68-7) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 6: Global Glabridin (CAS 59870-68-7) Market Size and Forecast by Type and Application Analysis

Chapter 7: North America Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: Europe Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: China Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: APAC (Excl. China) Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Latin America Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Middle East and Africa Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 13: Global Glabridin (CAS 59870-68-7) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 16: Research Findings and Conclusion

Chapter 17: Methodology and Data Sources